Dr Reddys Laboratories Share Price Today - Live Blog for November 17, 2025

The stock of Dr Reddys Laboratories Ltd has experienced a -0.06% drop, and it's now trading at ₹1,243.15 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd's share price has fallen by -0.17%, a situation worth noting. At present, the stock is trading at ₹1,243.15. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.1100, while the industry PE ratio is 33.4307.

With a -0.06% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,244.00. The stock is currently trading at a PE of 18.1100, while the industry PE is 33.4307, prompting investors to assess its value proposition.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.01%, signalling a challenging period. Currently trading at ₹1,244.65, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's stock has surged by 0.02%, and it is currently trading at ₹1,244.80. Additionally, the stock maintains a PE ratio of 18.1100, while the industry PE is 33.4307.

Dr Reddys Laboratories Ltd's share price has fallen by -0.01%, a situation worth noting. At present, the stock is trading at ₹1,245.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.1100, while the industry PE ratio is 33.4307.

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,245.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.1100, while the industry PE is 33.4307.

Dr Reddys Laboratories Ltd observed a remarkable 0.16% surge in its share price and is presently trading at ₹1,246.00. The increased investor interest is driving this surge.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.16%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,246.00 per share.

Dr Reddys Laboratories Ltd stock price decreased by -0.13%, with the current market value at ₹1,244.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.13% in its share price, and it currently trades at ₹1,244.00 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares experienced a -0.15% reduction, with the current market price at ₹1,246.10. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's shares experienced a 0.08% uptick, and they are currently valued at ₹1,247.95, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

After a significant 0.04% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,247.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.06%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,246.45 per share.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.02%, reaching a current market price of ₹1,246.80. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd observed a remarkable 0.10% surge in its share price and is presently trading at ₹1,247.00. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.02% uptick in its share price. As a result, it's now actively trading at ₹1,245.80 per share, making it an attractive option for investors.

After a -0.08% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,244.50. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

With a -0.08% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,245.45. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.1100, while the industry PE is 33.4307.

Dr Reddys Laboratories Ltd observed a -0.08% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,245.45. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.08% in its share price, and it currently trades at ₹1,245.45 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Following a noteworthy 0.02% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,247.00. When it comes to valuation, this stock has a PE ratio of 18.1100, with the industry PE ratio at 33.4307.

Dr Reddys Laboratories Ltd experienced a -0.10% dip in its share price and is currently trading at ₹1,246.25. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.10% in its share price, and it currently trades at ₹1,246.25 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.17%. At this moment, it's actively trading at ₹1,247.50, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd shares experienced a -0.10% reduction, with the current market price at ₹1,244.70. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's stock price surged by 0.01%, reaching the current market value of ₹1,244.55 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd experienced a -0.13% dip in its share price and is currently trading at ₹1,244.40. The stock has a PE ratio of 18.1100, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd remained stagnant, with no fluctuations. It is currently at ₹1,247.00. Investors may use this stability as an opportunity to reevaluate their portfolios and risk tolerance.